Novocure

BAAR, Switzerland | June 18, 2026 Novocure has announced topline results from its Phase 3 TRIDENT trial, which evaluated...

Baar, Switzerland – March 2026 Novocure announced positive topline results from its Phase 2 PANOVA-4 clinical trial evaluating Tumor...